Regencell Bioscience Holdings Ltd
RGC- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001829667
No open-market purchases or sales by Regencell Bioscience Holdings Ltd insiders were filed in the last 90 days; 35 institutions reported holding it in 13F filings for Q2 2026, worth $8.56M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Regencell Bioscience Holdings Ltd changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 14 | 16 | +2 |
| Shares | 691.7K | 633.8K | −57.9K (−8.4%) |
| Value | $11.8M | $9.79M | −$2.00M (−16.9%) |
New holders (7)
Institutions that held Regencell Bioscience Holdings Ltd at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Discovery Capital Management, LLC | 46,166 | $713.3K | 0.04% |
| XTX Topco Ltd | 38,735 | $598.5K | 0.03% |
| Vident Advisory, LLC | 18,068 | $279.2K | 0.00% |
| Jane Street Group, LLC | 10,616 | $164.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 357 | $5.52K | 0.00% |
| Simplex Trading, LLC | 217 | $3.00K | 0.00% |
| Group One Trading, L.P. | 100 | $1.54K | 0.00% |
Sold out (5)
Institutions that held Regencell Bioscience Holdings Ltd at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Schonfeld Strategic Advisors LLC | 52,100 | $887.8K |
| Y-Intercept (Hong Kong) Ltd | 13,042 | $222.2K |
| Greenfield Savings Bank | 11,000 | $187.4K |
| Raymond James Financial Inc | 71 | $1.21K |
| Citigroup Inc | 70 | $1.19K |